Fennec Pharmaceuticals (FENC) Asset Utilization Ratio (2020 - 2026)
Fennec Pharmaceuticals' (FENC) quarterly Asset Utilization Ratio came in at 0.75 in Q4 2025, down 18.59% YoY from 0.92 in Q4 2024, and down 9.58% on a QoQ basis from 0.82 in Q3 2025.
Fennec Pharmaceuticals (FENC) Asset Utilization Ratio (2020 - 2026) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 5 years of Asset Utilization Ratio data on file, last reported at 0.75 in Q4 2025.
- Quarterly Asset Utilization Ratio fell 18.59% year-over-year to 0.75 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.75 (down 18.59% YoY) and the FY2025 annual result came in at 0.77, down 41.61% from the prior year.
- Asset Utilization Ratio slipped to 0.75 in Q4 2025, from 0.82 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.94 in Q1 2024 to a low of 0.01 in Q1 2021.
- A 4-year average of 0.63 and a median of 0.74 in 2024 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2024 — Asset Utilization Ratio jumped 1115.68% — and 2025, when it decreased 27.69%.
- Tracing FENC's Asset Utilization Ratio over 4 years: stood at 0.01 in 2021, then surged by 13338.91% to 0.91 in 2023, then rose by 0.88% to 0.92 in 2024, then dropped by 18.59% to 0.75 in 2025.
- The last three Asset Utilization Ratio figures came in at 0.75 (Q4 2025), 0.82 (Q3 2025), and 0.73 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.69 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 186.67 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.13 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.90 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.54 |
| 10 | Fennec Pharmaceuticals | 410.60 Mn | 369.35 Mn | 17.15 Mn | 0.73 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.73 |
| Dec 31, 2025 | 0.75 |
| Sep 30, 2025 | 0.82 |
| Jun 30, 2025 | 0.73 |
| Mar 31, 2025 | 0.68 |
| Dec 31, 2024 | 0.92 |
| Sep 30, 2024 | 0.81 |
| Jun 30, 2024 | 0.74 |
| Mar 31, 2024 | 0.94 |
| Dec 31, 2023 | 0.91 |
| Sep 30, 2023 | 0.58 |
| Jun 30, 2023 | 0.25 |
| Mar 31, 2023 | 0.08 |
| Mar 31, 2021 | 0.01 |
| Dec 31, 2020 | 0.01 |